WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Down – Here’s Why

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $13.55, but opened at $12.48. WuXi Biologics (Cayman) shares last traded at $12.53, with a volume of 2,894 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One research analyst has rated the stock with a Hold rating. According to MarketBeat, the company currently has an average rating of “Hold”.

Get WuXi Biologics (Cayman) alerts:

Get Our Latest Research Report on WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Stock Performance

The company has a fifty day simple moving average of $12.80 and a two-hundred day simple moving average of $10.21.

About WuXi Biologics (Cayman)

(Get Free Report)

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.

Recommended Stories

• Five stocks we like better than WuXi Biologics (Cayman)
• Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen
• Birkenstock’s Strong Growth Creates a Buying Opportunity
• High Voltage Returns: Navitas Rewires AI Data Centers
• Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.